Karakus S

No ORCID on file · 3 papers in corpus
other 2016
Effect of imatinib on growth of experimental endometriosis in rats
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2015.12.013

OBJECTIVE: Currently, medical and surgical treatment options for endometriosis are limited due to suboptimal efficacy, and also safety and tolerance issues. Long-term use of gonadotrophin-releasing hormone analogs, androgenes, and the danaz…

article 2016
Elevated Serum CD95/FAS and HIF-1α Levels, but Not Tie-2 Levels, May Be Biomarkers in Patients With Severe Endometriosis: A Preliminary Report
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2016.01.025

Study objectiveTo evaluate serum values of cluster of differentiation 95 (CD95/FAS), hypoxia-inducible factor 1-alpha (HIF-1α), and tyrosine kinase receptor 2 (Tie-2) as possible biomarkers of disease presence and severity in women with end…

article 2015
Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115584448

We aimed to compare the effects of pazopanib, sunitinib, and sorafenib on endometriotic tissue morphology and histological characteristics as well as ovarian reserve in a rat model. Experimental endometriosis was established in 32 rats. The…